VIR insider sale notice: Sabatini 1,430 shares

Brent Sabatini filed a Form 144 reporting a proposed sale of Common stock tied to a Restricted Stock Vesting event dated 02/23/2026 for 1430 shares.

Accepted by SEC EDGAR 02/24/2026 - 04:53 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Brent Sabatini filed a Form 144 reporting a proposed sale of Common stock tied to a Restricted Stock Vesting event dated 02/23/2026 for 1430 shares. The excerpt also lists securities recorded as sold during the prior three months: 1530 on 02/13/2026 and 1829 on 02/23/2026.

Insights

Securities Compliance Specialist

Form 144 notice records planned insider sale linked to vesting.

The filing lists a proposed sale of Common stock tied to a Restricted Stock Vesting event on 02/23/2026 for 1430 shares. This is a routine notification under resale rules for insiders.

Cash‑flow treatment and broker/dealer methods are not shown in the excerpt; subsequent SEC filings or a broker disclosure would clarify execution details.

Equity Compensation Analyst

Vesting triggered a resale notice and prior short‑term disposals are listed.

The record ties the 1430‑share notice to a vesting event and lists two prior entries in the three‑month window: 1530 (02/13/2026) and 1829 (02/23/2026). These entries appear as transaction lines rather than broader plan changes.

Reporting focuses on individual transactions; timing and proceeds are not provided in the excerpt.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Brent Sabatini report on Form 144 for VIR?

He reported a proposed sale of Common stock tied to a Restricted Stock Vesting event for 1430 shares on 02/23/2026. The filing also lists two transactions in the prior three months: 1530 on 02/13/2026 and 1829 on 02/23/2026.

Does the Form 144 excerpt show proceeds or buyer details for the VIR shares?

No; the excerpt does not state sale proceeds, broker/dealer names, or execution methods. It lists share counts and dates but omits cash amounts and trading venue details that would show how the sales would be executed.

Is the 1430‑share entry part of compensation for VIR insiders?

Yes; the 1430 shares are linked in the excerpt to a Restricted Stock Vesting event dated 02/23/2026, indicating the shares arose from compensation rather than a market purchase or separate grant.

Do the listed prior transactions change beneficial ownership disclosed elsewhere for VIR?

The excerpt lists prior sale lines (1530 and 1829) but does not provide a post‑transaction beneficial ownership total. It does not state outstanding or remaining holdings tied to the reporting person in this excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002037272
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Vir Biotechnology, Inc.
SEC File Number	001-39083
Address of Issuer	1800 OWENS STREET SUITE 900 SAN FRANCISCO CALIFORNIA 94158
Phone	415-906-4324
Name of Person for Whose Account the Securities are To Be Sold	Sabatini Brent
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1430	13631.61	139517278	02/24/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/23/2026	Restricted Stock Vesting	Issuer			1430	02/23/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Brent Sabatini 1800 Owens Street Suite 900 San Francisco CA 94158	Common	02/13/2026	1530	11918.09
Brent Sabatini 1800 Owens Street Suite 900 San Francisco CA 94158	Common	02/23/2026	1829	13631.18

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	02/24/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Joshua Schmitt, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Brent Sabatini.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)